Irbesartan initiated the autophagy flux and relieved steatosis by modulating the PKC/AMPK/ULK1 axis (Figure 7), thus both autophagy and lipophagy are dynamic processes in hepatocytes. The gene discussed is PRRT2; the disease is steatosis.